The silencing of lncRNA PCAT6 changes RB/E2F and Wnt/β-catenin pathways by targeting miR-15a, inhibiting the proliferation and EMT of GC cells (Dong et al., 2020). The gene discussed is RB1; the disease is gastric cancer.